Rare
lephants
Screener
Toggle theme
Aclaris Therapeutics, Inc.
ACRS
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Revenue Breakdown
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Revenue Breakdown
←
5Y
10Y
MAX
→
Revenue Breakdown
Chart
Table
Contract research
Licensing
Fiscal Year
Contract research
Licensing
FY2024
$2.5M
$16.2M
FY2025
$1.9M
$6.0M
Download CSV
